Presentation Highlights News Today

Today's top stories for Netflix Inc. (NASDAQ: NFLX) cover the company's ambitious foray into cloud gaming, its triumphant Upfront presentation, and the upcoming removal of various titles from its platform. Let's delve into these three pivotal developments.

Latest small molecule drug conjugates (SMDCs) strengthen company strategy to discover and develop paradigm-shifting drug conjugates...

PALO ALTO, Calif., April 17, 2023 -- Vincerx Pharma, Inc. , a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting... | April 17, 2023

Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC), demonstrated superiority with significant...

GuruFocus Article or News written by GlobeNewswire and the topic is about:

VIP152 has increased selectivity and potency compared to other CDK9 inhibitors in development, consistent across DLBCL and CLL models of disease Vincerx...

VIP152 has increased selectivity and potency compared to other CDK9 inhibitors in development, consistent across DLBCL and CLL models of disease Vincerx hosting KOL webinar today, Saturday, December... | December 11, 2021

Session Dates: Friday, February 26 – Monday, March 1, 2021 Session Location: Virtual Poster Hall Poster No: L30 About ADMA Biologics, Inc. ADMA Biologics is an end-to-end American commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Dr...